Work

Results from a continuation trial of SU11248 in patients (pts) with imatinib (IM)-resistant gastrointestinal stromal tumor (GIST)

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.9011

Authors: R. G. Maki, J. A. Fletcher, M. C. Heinrich, J. A. Morgan, S. George, J. Desai, K. Scheu, C. D. M. Fletcher, C. Baum, G. D. Demetri

Institutions: Brigham and Women's Hospital, Pfizer (United States), Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center

Language: English

Topic: Gastrointestinal Tumor Research and Treatment

Subfield: Gastroenterology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2581960448

Cites:

Cited by: 109

Related to: 10